Healthcare provider profile · identity verified

Collin Wade Lynn, MD

Family Practice · REDDING, CA · NPI 1083770754

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	205	37
Levothyroxine Sodium	Levothyroxine Sodium	161	31
Atorvastatin Calcium	Atorvastatin Calcium	159	39
Lisinopril	Lisinopril	156	40
Omeprazole	Omeprazole	133	32
Baclofen	Baclofen	127	27
Albuterol Sulfate Hfa	Albuterol Sulfate	124	38
Pantoprazole Sodium	Pantoprazole Sodium	121	33
Hydrochlorothiazide	Hydrochlorothiazide	117	23
Trazodone Hcl	Trazodone Hcl	117	26
Metformin Hcl	Metformin Hcl	116	26
Fluticasone Propionate	Fluticasone Propionate	96	25
Furosemide	Furosemide	88	19
Sertraline Hcl	Sertraline Hcl	79	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	77	15
Ibuprofen	Ibuprofen	76	20
Losartan Potassium	Losartan Potassium	75	21
Hydroxyzine Hcl	Hydroxyzine Hcl	74	13
Tamsulosin Hcl	Tamsulosin Hcl	74	17
Amitriptyline Hcl	Amitriptyline Hcl	70	13
Rosuvastatin Calcium	Rosuvastatin Calcium	69	18
Zolpidem Tartrate	Zolpidem Tartrate	69	12
Montelukast Sodium	Montelukast Sodium	67	16
Amlodipine Besylate	Amlodipine Besylate	64	26
Ozempic	Semaglutide	64	11
Potassium Chloride	Potassium Chloride	64	15
Tramadol Hcl	Tramadol Hcl	63	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	59	13
Meloxicam	Meloxicam	58	12
Famotidine	Famotidine	56	15
Fluoxetine Hcl	Fluoxetine Hcl	56	suppressed
Duloxetine Hcl	Duloxetine Hcl	55	11
Simvastatin	Simvastatin	55	suppressed
Alendronate Sodium	Alendronate Sodium	53	11
Bupropion Xl	Bupropion Hcl	49	12
Eliquis	Apixaban	48	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	45	suppressed
Buspirone Hcl	Buspirone Hcl	45	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	suppressed
Lamotrigine	Lamotrigine	45	suppressed
Risperidone	Risperidone	42	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	41	13
Januvia	Sitagliptin Phosphate	41	suppressed
Atenolol	Atenolol	37	suppressed
Ventolin Hfa	Albuterol Sulfate	37	suppressed
Diclofenac Sodium	Diclofenac Sodium	36	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	36	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	36	14
Metoprolol Succinate	Metoprolol Succinate	35	13
Propranolol Hcl	Propranolol Hcl	35	suppressed
Carbamazepine Er	Carbamazepine	34	suppressed
Carvedilol	Carvedilol	34	suppressed
Benztropine Mesylate	Benztropine Mesylate	33	suppressed
Olanzapine	Olanzapine	33	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	32	suppressed
Testosterone Cypionate	Testosterone Cypionate	30	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Pravastatin Sodium	Pravastatin Sodium	29	suppressed
Clonidine Hcl	Clonidine Hcl	28	suppressed
Estradiol	Estradiol	28	suppressed
Levetiracetam	Levetiracetam	28	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Nitroglycerin	Nitroglycerin	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Felbamate	Felbamate	26	suppressed
Topiramate	Topiramate	26	suppressed
Clonazepam	Clonazepam	25	suppressed
Ondansetron Odt	Ondansetron	25	suppressed
Trulicity	Dulaglutide	24	suppressed
Celecoxib	Celecoxib	23	suppressed
Benazepril Hcl	Benazepril Hcl	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Naproxen	Naproxen	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Allopurinol	Allopurinol	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Prednisone	Prednisone	20	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Finasteride	Finasteride	18	suppressed
Lactulose	Lactulose	18	suppressed
Lorazepam	Lorazepam	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Azithromycin	Azithromycin	17	13
Divalproex Sodium	Divalproex Sodium	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Nystatin	Nystatin	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Clomipramine Hcl	Clomipramine Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Testosterone	Testosterone	13	suppressed
Zonisamide	Zonisamide	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Diazepam	Diazepam	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Naloxone Hcl	Naloxone Hcl	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Prednisolone Acetate	Prednisolone Acetate	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error